Latest Press Releases

How to Engineer a Stronger Immune System
FEATURED
Press Release Aug 8, 2016
How to Engineer a Stronger Immune System
Gladstone Scientists Funded by NIH to Dive Deep Into ApoE4's Role in Alzheimer's Disease
Press Release Jan 29, 2020
Gladstone Scientists Funded by NIH to Dive Deep Into ApoE4's Role in Alzheimer's Disease

With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.
New Small Molecule to Treat Alzheimer's Disease and Dravet Syndrome
Press Release Jan 14, 2020
New Small Molecule to Treat Alzheimer's Disease and Dravet Syndrome

New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.
$13 Million Grant to Probe the Genome of Heart Cells
Press Release Dec 17, 2019
$13 Million Grant to Probe the Genome of Heart Cells
New Cohort of Board Members Brings New Insights From Bay Area Business Sectors
Press Release Dec 16, 2019
New Cohort of Board Members Brings New Insights From Bay Area Business Sectors

Five new members join the Gladstone Foundation Board
Gladstone Researchers Used a Machine-Learning Approach to Discover New Ways of Controlling the Spatial Organization of Induced Pluripotent Stem Cells
Press Release Nov 20, 2019
Gladstone Researchers Used a Machine-Learning Approach to Discover New Ways of Controlling the Spatial Organization of Induced Pluripotent Stem Cells

Machine, Meet Stem Cells
Predicting Alzheimer's Disease-Like Memory Loss Before It Strikes
Press Release Nov 19, 2019
Predicting Alzheimer's Disease-Like Memory Loss Before It Strikes

New study shows how patterns in brain activity can be an early predictor of Alzheimer's symptoms
$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer's Disease
Press Release Oct 31, 2019
$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer's Disease

NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.
Gladstone Investigators and Xyphos Partner to Successfully Adapt CAR-T Immunotherapy to Target the HIV Latent Reservoir
Press Release Oct 24, 2019
Gladstone Investigators and Xyphos Partner to Successfully Adapt CAR-T Immunotherapy to Target the HIV Latent Reservoir

Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.
New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer's Disease
Press Release Oct 8, 2019
New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer's Disease

The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego